These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 11511841)
21. Antibiotics used in nonbacterial dermatologic conditions. Gordon RA; Mays R; Sambrano B; Mayo T; Lapolla W Dermatol Ther; 2012; 25(1):38-54. PubMed ID: 22591498 [TBL] [Abstract][Full Text] [Related]
22. Generalized lichen planus in childhood: is dapsone an effective treatment modality? Başak PY; Başak K Turk J Pediatr; 2002; 44(4):346-8. PubMed ID: 12458814 [TBL] [Abstract][Full Text] [Related]
23. The response of generalized granuloma annulare to dapsone. Czarnecki DB; Gin D Acta Derm Venereol; 1986; 66(1):82-4. PubMed ID: 2424227 [TBL] [Abstract][Full Text] [Related]
24. Botryomycosis-like pyoderma in the genital region of a human immunodeficiency virus (HIV)-positive man successfully treated with dapsone. Rubenstein E; Krulig E; Cardenas V; Kerdel FA Int J Dermatol; 2010 Jul; 49(7):842-3. PubMed ID: 20618509 [No Abstract] [Full Text] [Related]
25. Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. Sterling JB; Heymann WR J Am Acad Dermatol; 2000 Oct; 43(4):691-7. PubMed ID: 11004629 [TBL] [Abstract][Full Text] [Related]
26. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers. Edstein MD; Rieckmann KH Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124 [TBL] [Abstract][Full Text] [Related]
27. Hidradenitis suppurativa treated with dapsone: A case series of five patients. Kaur MR; Lewis HM J Dermatolog Treat; 2006; 17(4):211-3. PubMed ID: 16971313 [TBL] [Abstract][Full Text] [Related]
28. How does dapsone work in immune thrombocytopenia? Implications for dosing. Hill QA Blood; 2015 Jun; 125(23):3666-8. PubMed ID: 26045596 [No Abstract] [Full Text] [Related]
29. Successful treatment of Melkersson-Rosenthal syndrome with dapsone and triamcinolone injections. Sobjanek M; Włodarkiewicz A; Zelazny I; Nowicki R; Michajłowski I; Sokołowska-Wojdyło M J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1028-9; author reply 1027-8. PubMed ID: 19522917 [No Abstract] [Full Text] [Related]
31. Update on the dermatologic use of systemic glucocorticosteroids. Jackson S; Gilchrist H; Nesbitt LT Dermatol Ther; 2007; 20(4):187-205. PubMed ID: 17970885 [TBL] [Abstract][Full Text] [Related]
32. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone. Sharquie KE; Najim RA; Al-Hayani RK; Al-Nuaimy AA; Maroof DM Saudi Med J; 2008 May; 29(5):734-8. PubMed ID: 18454224 [TBL] [Abstract][Full Text] [Related]
33. [Oral contraceptives in dermatology]. Sancho B; Guerra-Tapia A Actas Dermosifiliogr; 2009; 100(6):445-55. PubMed ID: 19709548 [TBL] [Abstract][Full Text] [Related]
34. Dapsone use in Loxosceles reclusa envenomation: is there an indication? Bryant SM; Pittman LM Am J Emerg Med; 2003 Jan; 21(1):89-90. PubMed ID: 12563594 [No Abstract] [Full Text] [Related]
35. Methotrexate in dermatology. Bangert CA; Costner MI Dermatol Ther; 2007; 20(4):216-28. PubMed ID: 17970887 [TBL] [Abstract][Full Text] [Related]
36. [Sulfones--dermatologic indications and side effects]. Wozel G; Hackert I Dermatol Monatsschr; 1986; 172(9):513-22. PubMed ID: 3792594 [No Abstract] [Full Text] [Related]